Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivoligide in Total Knee Arthroplasty
NCT02807428Phase 2Completed
- Sponsor
- Adynxx, Inc.
- Start
- Feb 2017
- Primary completion
- Oct 2017
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of brivoligide in postoperative pain, sponsored by Adynxx, Inc.. Started Feb 2017; status: completed.
02
Drugs
brivoligide
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02807428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807428.